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 BACKGROUND:  Th ere is a wide variability in measurement methodology of physical activity. 
Th is study investigated the eff ect of diff erent analysis techniques on the statistical power of 
physical activity outcomes aft er pulmonary rehabilitation. 
 METHODS:  Physical activity was measured with an activity monitor armband in 57 patients 
with COPD (mean   SD age, 66   7 years; FEV 1 , 46   17% predicted) before and aft er 3 months 
of pulmonary rehabilitation. Th e choice of the outcome (daily number of steps [STEPS], time 
spent in at least moderate physical activity [TMA], mean metabolic equivalents of task level 
[METS], and activity time [ACT]), impact of weekends, number of days of assessment, post-
processing techniques, and infl uence of duration of daylight time (DT) on the sample size to 
achieve a power of 0.8 were investigated. 
 RESULTS:  Th e STEPS and ACT (1.6-2.3 metabolic equivalents of task) were the most sensitive 
outcomes. Excluding weekends decreased the sample size for STEPS (83 vs 56), TMA (160 
vs 148), and METS (251 vs 207). Using 4 weekdays (STEPS and TMA) or 5 weekdays (METS) 
rendered the lowest sample size. Excluding days with  , 8 h wearing time reduced the sample 
size for STEPS (56 vs 51). Diff erences in DT were an important confounder. 
 CONCLUSIONS:  Changes in physical activity following pulmonary rehabilitation are best mea-
sured for 4 weekdays, including only days with at least 8 h of wearing time (during waking 
hours) and considering the diff erence in DT as a covariate in the analysis. 
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 ABBREVIATIONS:  DT  5 duration of daylight time; ICC  5 intraclass 
correlation coeffi  cient; METs  5 metabolic equivalents of task; METS  5 
mean metabolic equivalents of task level; STEPS  5 daily number of steps; 
TMA  5 time spent in at least moderate physical activity 
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 In patients with COPD, physical inactivity is believed to 
play a crucial role in the development of comorbidities 
(ie, skeletal muscle weakness, osteoporosis, depression, 
exercise intolerance, cardiovascular disease). 1-3 More-
over, physical inactivity is an independent predictor of 
adverse outcome 4,5 and aff ects quality of life. 6,7 Increasing 
physical activity has become a patient-centered goal for 
the treatment of patients with COPD. Unfortunately, 
the literature suggests that aft er following a pulmonary 
rehabilitation program, an enhancement of physical 
activity is not guaranteed. 8,9 Th e lack of statistically sig-
nifi cant improvements can be due to a failure of inter-
ventions to achieve behavioral changes or to the 
conduct of underpowered studies unable to account for 
the variability in the outcome measure. 
 Physical activity is characterized by large variability 
because it is measured under unstandardized condi-
tions. Recommendations identify the need for optimal 
activity monitor schedules in fi eld research. 10 Factors 
aff ecting standardization are related to intrinsic diff er-
ences in physical activity levels from day-to-day, extrin-
sic variability (ie, climatologic conditions, seasons 11,12 ); 
the measurement itself (ie, the monitor, the number of 
days of assessment, the number of hours of measure-
ment); and postprocessing (ie, days and time use in the 
analysis). Minimizing the noise around the measure of 
physical activity can enhance the statistical power of 
studies, whereas minimizing the number of days and 
hours of assessment reduces the burden to patients, 
which may contribute to study compliance. 
 Th e aim of the present study was to fi nd a standardized 
method of physical activity measurement and data 
analysis to improve the power of physical activity-
related outcomes, predominantly by reducing the vari-
ability of the outcomes and optimizing the eff ect size. 
We explored the following research questions: What is 
the impact of (1) the chosen outcome, (2) the exclusion 
of weekends, (3) increasing the number of days of 
assessment, and (4) altering the postprocessing analysis 
techniques (eg, time set used, defi nition of valid days 
according to wearing time, correction for daylight 
time)? 
 We hypothesized that the variability in physical activity 
can be reduced by excluding weekends, using more 
assessment days, comparing the same days of the week at 
both time points, using a fi xed time frame for physical 
activity analysis (eg, 7:00  am -8:00  pm ), and omitting 
days with a low monitor wearing time. Previous 
studies 13-17 identifi ed the number of days of assessment 
through cross-sectional data analysis. Th e present study 
compared the impact of diff erent techniques of analysis 
on the intervention eff ect aft er rehabilitation. 
 Materials and Methods 
 Study Subjects and Design 
 Th e baseline and 3-month data of a rehabilitation study (Clinical Trials 
registry No.: NCT00948623; approved by UZ Leuven Medical Ethics 
Committee [B32220095599]) were used to investigate variability in 
physical activity. Patients with stable COPD 2 (no exacerbations in pre-
ceding 4 weeks) referred for outpatient pulmonary rehabilitation were 
randomly assigned to a conventional rehabilitation group (described 
in detail elsewhere 18 ) or a conventional rehabilitation plus counseling 
group. In the present analysis, both groups are combined. Th e sample 
size calculation of the original study was based on the primary aim of 
the rehabilitation study; hence, the present sample should be seen as a 
convenience sample and was judged to be appropriate for the present 
(sub)analysis. Th is judgment was based on a sensitivity analysis where 
random patients were left  out of the analysis, which showed no change 
in mean and SD of the eff ect (e-Appendix 1). In addition, the present 
study sample is one of the larger samples analyzing the (objectively 
measured) physical activity of patients undergoing pulmonary rehabil-
itation. 9 Fift y-seven of the subjects already had accelerometer data fi les 
both at baseline and aft er 3 months. Th ese data were retrieved for this 
investigation. Informed consent was obtained prior to the start of the 
study. More information can be found in e-Appendix 1. 
 Clinical Measurements 
 All subjects underwent spirometry (Jaeger MasterScreen Body; 
CareFusion Corp) according to European Respiratory Society and 
American Th oracic Society standards. Th e results were referred to the 
predicted normal values proposed by Quanjer et al. 19 A 6-min walk test 
was performed in a 50-m corridor, and the best of two tests was used. 20 
 Physical activity was measured before and immediately aft er reha-
bilitation for 7 consecutive days with the SenseWear Pro armband 
(BodyMedia, Inc), which detects wearing time directly by skin contact. 21 
Th e SenseWear Pro armband has been thoroughly validated. 22-24 
 Subjects were asked to wear the monitor whenever awake. Th ey refrained 
from their rehabilitation program in the week of the physical activity 
assessment. Th e minute-by-minute output of the number of steps and 
metabolic equivalents of task (METs) was exported for further analysis 
using SenseWear Professional, version 6.0 soft ware (BodyMedia, Inc). 
 Th e variables chosen for this analysis were the total daily number of 
steps (STEPS); daily time spent in at least moderate physical activity 
(TMA), defi ned as any activity   3 METs 25 ; and daily mean METs level 
(METS). Active time was also defi ned at lower thresholds (between 1 
and 3 METs) using a 0.1-MET increase (e-Appendix 1). 
 Data Treatment 
 The full analysis set comprised all available minute-by-minute data 
before and aft er rehabilitation. From the full analysis set, several datasets 
were constructed to test various hypotheses (e-Appendix 1). 
 Duration of daylight time (DT) has been suggested as a proxy for seasonal-
ity. DT of each measured day was predicted using the CSIRO (Common-
wealth Scientifi c and Industrial Research Organisation) Biosphere model, 
with a day length coeffi  cient of 0.8333 and latitude of 50.78° ( Fig 1 ). 26 
 Statistics 
 Minute-by-minute datasets were analyzed with SAS, version 9.3 (SAS 
Institute Inc) statistical soft ware. Two diff erent approaches were used to 
identify the impact of standardization: 
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 Results 
 Subjects 
 Fift y-seven subjects with COPD were analyzed. Th e sub-
ject characteristics are shown in  Table 1 . 
 Impact of Outcome Used 
 A summary of the eff ect and variability of the interven-
tion is provided in  Table 2 . Th e choice of the physical 
activity outcome used (STEPS, TMA, METS) had 
important implications in identifying intervention 
eff ects. Use of a 7-day measurement (mean eff ect com-
pared with baseline, 21% for STEPS, 29% for TMA, 
and 4% for METS) resulted in a calculated sample size 
of 83 subjects for STEPS, 160 for TMA, and 215 for 
METS. Th e use of an activity threshold between 1.3 
and 2.3 METs lowered the sample size (lowest at 1.3 
METs, 69 subjects) (e-Appendix 1). 
 Impact of Days of Assessment 
 Excluding weekends did not have an impact on the 
intervention eff ect but did decrease the sample size to 
achieve the intended power ( Fig 2 ) (33% [56 subjects 
vs 83 subjects] for STEPS, 4% [207 subjects vs 215 sub-
jects] for METS, and 8% [148 subjects vs 160 subjects] 
for TMA) because of a reduction of the SD of the eff ect 
( Table 2 ). Th e sample size decreased gradually until 
4 days of measurement for STEPS and TMA and until 
5 days for METS ( Fig 2 ). Comparing the same weekdays 
prerehabilitation and postrehabilitation did not enhance 
the robustness for any of the outcome measurements 
and resulted in a loss of subjects with no valid compa-
rable data before and aft er intervention. 
 Solely based on achieving an acceptable reliability 
(ICC  . 0.8), one would conclude that 2 days for 
STEPS (ICC  5 0.85), TMA (ICC  5 0.87), and METS 
(ICC  5 0.89) would be suffi  cient. Th e ICC further 
increased up until 5 weekdays of measurement (STEPS, 
0.93; TMA, 0.93; METS, 0.93) but slightly worsened 
when including the weekend days (STEPS, 0.90; TMA, 
0.92; METS, 0.92) for all outcomes ( Fig 2 ). Analysis of 
the repeatability coeffi  cient showed a comparable result 
with a gradual decrease from 2 to 5 weekdays (STEPS, 
1,157 steps/d vs 497 steps/d; TMA, 66 min vs 41 min; 
METS, 0.25 vs 0.19 METs). 
 Figure 1 –  Formula used to calculate daylight time based on the day of 
the year and latitude (CSIRO [Commonwealth Scientifi c and Industrial 
Research Organisation] Biosphere model). 26 Α day length coeffi  cient of 
0.8333° (US government defi nition of day length) and a latitude of 
50.78° (Belgium) were used to predict the daylight time. Northern lati-
tudes are positive, southern latitudes are negative, and daylight time is 
calculated in hours (and converted to minutes ). 
 TABLE 1  ]  Baseline Subject Characteristics 
Characteristic Baseline Value
Sex
 Male 47 (82)
 Female 10 (18)
Age, y 66   7
BMI, kg/m 2 26   7
FEV 1 , L 1.28   0.46
FEV 1 , % predicted 46   17
FVC, L 3.10   0.79
FVC % predicted 88   22
FEV 1 /FVC, % 41   11
GOLD stage
 I 4 (7)
 II 15 (26)
 III 29 (51)
 IV 9 (16)
6MWD, m 427   105
6MWD, % predicted 67   17
 Data are presented as No. (%) or mean   SD. 6MWD  5 6-min walk 
distance; GOLD  5 Global Initiative for Chronic Obstructive Lung Disease. 
 1.  Similar to previous cross-sectional research, 13-17 the intraclass 
correlation coeffi  cient (ICC) of the baseline measurement was 
used to assess reliability and identify the optimal number of 
days of measurement. Th e usually desired ICC value for multiple 
days is 0.80. 17 In addition, the repeatability coefficient of the 
baseline measurement was calculated as a measure of absolute 
reliability. 27 
 2.  Based on data of the intervention eff ect, robustness of the mea-
surement was expressed as the sample size needed to achieve a 
power of 0.8 with a signifi cance level  a  5 .05. Sample size calcu-
lation (two-tailed) was done with an a priori power calculation 
using G*Power 3.1.3. 28 
 To identify a diff erence between the analysis techniques, a paired  t test 
was performed. Th e infl uence of a diff erence in DT on the intervention 
eff ect was studied using a mixed-model analysis. Th e corrected interven-
tion and interaction eff ects (  PA  3   DT [where PA  5 physical activity]) 
were retrieved.  P  , .05 was considered statistically signifi cant. 
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 TABLE 2  ]  Infl uence of the Outcome Used, Exclusion of Weekends, and Number of Days of Measurement on 
the Calculated Sample Size 
Outcome Baseline 3 mo   p5-p95  P Value
STEPS, No./d
 2 d 4,038   2,783 4,837   3,333 799   2,625  2 2,683 to 7,629 .0253
 3 d 3,989   2,639 4,814   3,222 824   2,495  2 2,126 to 4,815 .0156
 4 d 3,966   2,636 4,932   3,381 967   2,505  2 1,775 to 5,212 .0051
 5 d 3,931   2,566 4,846   3,257 916   2,392  2 1,599 to 4,948 .0055
 7 d 3,892   2,656 4,692   3,284 800   2,560  2 1,771 to 9,183 .0218
TMA, min/d
 2 d 51   64 62   64 11   67  2 116 to 134 .2199
 3 d 50   58 64   77 14   69  2 76 to 176 .1309
 4 d 50   58 66   78 16   67  2 67 to 161 .0784
 5 d 50   55 64   75 15   63  2 58 to 158 .0855
 7 d 49   52 63   76 14   63  2 66 to 153 .0976
METS
 2 d 1.333   0.28 1.375   0.33 0.042   0.29  2 0.445 to 0.478 .2792
 3 d 1.331   0.26 1.379   0.34 0.048   0.31  2 0.417 to 0.464 .2447
 4 d 1.332   0.26 1.388   0.35 0.056   0.30  2 0.402 to 0.401 .1640
 5 d 1.327   0.26 1.383   0.34 0.055   0.28  2 0.371 to 0.485 .1450
 7 d 1.319   0.24 1.374   0.35 0.055   0.29  2 0.271 to 0.424 .1524
 Data are presented as mean   SD.    5 found intervention eﬀ ect; METS  5 mean metabolic equivalents of task level; p5-p95  5 percentile 5 to percentile 
95 of the found intervention eﬀ ect; STEPS  5 daily number of steps; TMA  5 time spent in at least moderate physical activity. 
 Diﬀ erence in Postprocessing Analysis 
 Subjects were most active between 7:00  am and 8:00  pm 
( Fig 3A) . During this period, 84% of steps were captured 
( Fig 3B) . Th e infl uence of the various analysis techniques 
is shown in  Table 3 . Altering the postprocessing technique 
had little to no impact on the statistical signifi cance of 
the intervention’s eff ect for any of the outcomes. 
 Excluding data recorded before 7:00  am and aft er 8:00  pm 
reduced the sample size needed for METS. Analyzing 
days with a valid wearing time (a minimum of 480 min) 
reduced the sample size needed for STEPS ( Table 3 ). 
Excluding days of  , 12 h wearing time had no further 
impact on the sample size but resulted in the loss of 
seven subjects (12%) who lacked valid days of assessment 
in this scenario. 
 Sixteen subjects (28%) started in winter, 19 (33%) in 
spring, 16 (28%) in summer, and six (11%) in autumn, 
with a mean DT measurement of 758   180 min at base-
line and 731   167 min at 3 months. For all outcome 
measurements, the diff erence in DT had a signifi cant 
infl uence on the intervention eff ect. Th e impact of DT 
remained in all scenarios of postprocessing. Correcting 
 Figure 2 –  Infl uence of the number of days of measurement and exclusion of weekend days on the calculated sample size and ICC. A, Sample size 
needed to achieve a power of 0.8 with a signifi cance level of .05 (STEPS, TMA, and METS) in 2 to 5 (random) weekdays and a whole week of measure-
ment. B, ICCs (STEPS, TMA, and METS) in 2 to 5 (random) weekdays and a whole week of measurement. ICC  5 intraclass correlation coeffi  cient; 
METS  5 mean metabolic equivalents of task level; TMA  5 time spent in at least moderate physical activity; STEPS  5 daily number of steps. 
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 Figure 3 – Whole-day physical activity pattern. Mean min-by-min physical activity pattern (all data, 7 d) of all patients. A, Mean METs per minute, 
presented as mean   SEM (gray). B, Proportion of total number of steps measured presented min by min. METs  5 metabolic equivalents of task. 
for the diff erence in DT resulted in slightly larger inter-
vention eff ects, which further reduced the sample size 
requirements ( Table 4 ). 
 Discussion 
 Th e present study showed that the choice of outcome 
and the processing of physical activity data had impor-
tant implications for the statistical signifi cance of the 
results. Th ese methodologic choices, thus, aff ect the 
number of subjects required in a study. Excluding week-
ends improved the robustness, as did the inclusion of 
more weekdays. A diff erence in DT had an important 
infl uence on the observed change in physical activity. 
We hypothesized that this eff ect would be counteracted 
by limiting the assessment time to between 7:00  am  and 
 8:00  pm , but this was not the case. Th e methodology of 
data processing has a signifi cant impact on the outcome 
and estimates of eff ect, which was also highlighted by 
the American College of Sports Medicine. 10 
 Data provided by activity monitors are commonly used 
to measure daily physical activity. In patients with 
COPD, validation studies highlighted the usability and 
validity of measures of physical activity compared with 
a gold standard methodology. 23,24 Promoting physical 
activity has become an increasingly important part of 
the treatment of patients with COPD. Th e measurement 
of physical activity, therefore, is of indisputable clinical 
importance. Activity monitor-based counseling pro-
grams are proven to have a benefi cial eff ect in patients 
with chronic diseases, 29 and clear physical activity guide-
lines for promoting health are widely used. 30 For clini-
cians, standardization of measurements, as proposed in 
the present study, can provide a clear benchmark of nor-
mal and abnormal physical activity and can be used for 
clinical comparisons before and after interventions . 
In some paradigms (eg, coaching patients toward a 
more active lifestyle), full data including weekends may 
be valuable. Th e main outcome chosen for the present 
study was the sample size needed to achieve a power of 
0.80. Th e statistical power is the probability that the null 
hypothesis will be rejected when it is truly false (type II 
error). 28 Analyzing the power of a study depends on the 
signifi cance level  a , the sample size, and the eff ect size. 
Th e latter depends on the average diff erence and the var-
iability of the measurement. Th e present study took sev-
eral approaches into account to reduce variability. 
 Comparing the same days (ie, Monday to Monday) was 
hypothesized to control for diff erences in patients’ 
weekly routines and, hence, decrease the variability. Th e 
data suggest that a systematic day-to-day pattern is 
absent, similar to observations in healthy subjects com-
parably aged 31 and patients with COPD. 32 Th erefore, we 
confi dently suggest that correcting for weekly routines 
is not necessary. Th e exclusion of weekends could 
decrease the variability of the physical activity measure-
ment and did not aff ect the intervention eff ect. 
 Previously, at least 2, 14 3, 15,16 5, 17 and 7 13 days of assess-
ment were suggested for physical activity measurement. 
Th ese cross-sectional studies were mainly based on the 
obtained ICC and assumed the reliability of the baseline 
measurement only. Similarly, we would have concluded 
a minimum of 2 days of measurement needed for reli-
able data (ICC  . 0.8). In a longitudinal design, however, 
including more days clearly enhanced the robustness. 
Th e reliability coeffi  cient is a useful index for quanti-
fying absolute reliability using the same units as the 
measurement tool. 27 Th e reliability coeffi  cient is also 
referred to as the smallest real diff erence and shows that 
more days of measurement can halve the minimal detect-
able diff erence needed to prove that an eff ective inter-
vention can increase the number of steps. 
 In healthy adults, at least 3 weekdays are needed to 
achieve a suffi  cient ICC for physical activity level, and 
 journal.publications.chestnet.org  323 
5 weekdays are needed for STEPS. 21 Th e present results 
showed no diff erence in ICC among the various out-
comes. Based on the sample sizes, the most sensitive 
outcome to fi nd diff erences is STEPS, which is explained 
by (1) a reasonable change (20% vs only 5% in average 
METs) and (2) a manageable SD. It seems that motion-
related outcomes (ie, number of steps) better refl ect 
changes in physical activity following rehabilitation 
compared with other physical activity outcomes (ie, 
energy expenditure). Th e use of a light-intensity activity 
threshold (1.6-2.3 METs) instead of the defi ned mod-
erate physical activity level reduced the needed sample 
size and almost approached the sample size needed for 
STEPS. TMA is an outcome measurement that is diffi  -
cult to alter and is probably out of reach for many 
patients with COPD, even following rehabilitation 
(e-Appendix 1). 
 Because of the association with mortality and morbidity 
in patients with chronic diseases (oft en independent of 
physical activity levels) increasing attention is given to 
the measurement of sedentary behavior. 33,34 Sedentary 
behavior has been defi ned as any waking behavior char-
acterized by an energy expenditure of   1.5 METs while 
 TABLE 3  ]  Infl uence of Various Analysis Techniques on the Calculated Sample Size (Measurement Based on 
5 Weekdays) 
Technique Baseline 3 mo   p5-p95  P Value Sample Size
STEPS, No./d
 All data 3,931   2,565 4,846   3,257 916   2,392  2 1,599 to 4,948 .0055 56
 7:00  AM -8:00  PM 3,664   2,456 4,529   3,143 866   2,298  2 1,430 to 4,963 .0062 58
  . 480 min 3,981   2,602 4,927   2,364 946   2,364  2 1,631 to 4,948 .0038 51
  . 600 min 4,026   2,666 4,988   3,253 962   2,445  2 1,631 to 4,948 .0044 53
 Combination 3,711   2,464 4,652   2,272 941   2,272  2 1,352 to 4,963 .0028 48
TMA, min/d
 All data 50   55 64   74 15   63  2 58 to 158 .0855 148
 7:00  AM -8:00  PM 48   53 61   69 13   60  2 58 to 115 .0957 158
  . 480 min 50   56 65   75 15   63  2 61 to 158 .0873 150
  . 600 min 51   57 66   76 15   65  2 61 to 158 .0895 152
 Combination 48   53 62   69 14   60  2 58 to 115 .0903 153
METS
All data 1.327   0.26 1.375   0.34 0.055   0.28  2 0.445 to 0.478 .1450 207
 7:00  AM -8:00  PM 1.395   0.29 1.466   0.36 0.071   0.30  2 0.428 to 0.626 .0763 140
  . 480 min 1.330   0.26 1.387   0.34 0.057   0.29  2 0.371 to 0.485 .1349 197
  . 600 min 1.330   0.26 1.388   0.34 0.058   0.29  2 0.371 to 0.488 .1418 204
 Combination 1.395   0.29 1.467   0.36 0.072   0.30  2 0.428 to 0.626 .0780 141
Wearing time, min/d 
 All data 890   808 916   812 … … … …
  No. d 4.75 4.37 … … … …
 7:00  AM -8:00  PM 689   62 680   83 … … … …
  No. d 4.72 4.37 … … … …
  . 480 min 901   223 924   255 … … … …
  No. d 4.67 4.25 … … … …
  . 600 min 912   233 932   256 … … … …
  No. d 4.53 4.09 … … … …
 Combination 698   57 697   65 … … … …
  No. d 4.58 4.12 … … … …
 Data are presented as mean   SD unless otherwise indicated. 7:00  AM -8:00  PM  5 data exclusion before 7:00  AM and after 8:00  PM ;  . 480 min  5 exclusion 
of days with   480 min of wearing time;  . 600 min  5 exclusion of days with   600 min of wearing time; combination  5 included data between 7:00  AM 
and 8:00  PM of days with minimum of 480 min of wearing time in this period. See  Table 2 legend for expansion of other abbreviations. 
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 TABLE 4  ]  The Infl uence of Daylight Time on the Intervention Effect and Calculated Sample Size 
(Measurement Based on 5 Weekdays) 
Intervention Eﬀ ect (  ) Unadjusted a Interaction Eﬀ ect b Intervention Eﬀ ect (  ) Adjusted c 
Technique Mean   SD  P Value  P Value Mean   SD  P Value Sample Size
STEPS, No./d
 All data 916   2,392 .0055 .0129 990   2,291 .0019 44
 7:00  AM -8:00  PM 866   2,298 .0062 .0217 932   2,219 .0025 47
  . 480 min 946   2,364 .0038 .0079 1,024   2,247 .0011 40
  . 600 min 962   2,445 .0044 .0023 1,055   2,276 .0009 39
 Combination 941   2,272 .0028 .0203 1,007   2,192 .0010 40
TMA, min/d
 All data 15   63 .0855 .0016 17   58 .0314 94
 7:00  AM -8:00  PM 13   60 .0957 .0030 16   56 .0395 99
  . 480 min 15   63 .0873 .0014 17   59 .0316 97
  . 600 min 15   65 .0895 .0006 18   59 .0284 87
 Combination 14   60 .0903 .0027 16   56 .0361 99
METS
 All data 0.055   0.28 .1450 .0101 0.065   0.27 .0767 138
 7:00  AM -8:00  PM 0.071   0.30 .0763 .0028 0.080   0.28 .0297 99
  . 480 min 0.057   0.29 .1349 .0092 0.067   0.27 .0696 130
  . 600 min 0.058   0.29 .1418 .0052 0.068   0.28 .0686 136
 Combination 0.072   0.30 .0780 .0024 0.083   0.28 .0298 92
 See  Table 2 and 3 legends for expansion of abbreviations. 
 a Uncorrected intervention eﬀ ect. 
 b Interaction eﬀ ect (intervention eﬀ ect  3   daylight time ). 
 b Corrected intervention eﬀ ect for   daylight time, using mixed-model analysis. 
in a sitting or reclining posture. 35 Th e SenseWear arm-
band does not record information on changes in pos-
ture; therefore, the results discussed in the present study 
only relate to physical activity measurement and not to 
standardization of sedentary behavior data collection. 
In healthy elderly people, more days of measurement 
are needed to reliably (ICC  . 0.80) assess sedentary data 
(7 days) in cross-sectional analyses. 31,36 Th us, we hypoth-
esize that more days and hours of wearing time are 
needed to analyze sedentary behavior in patients with 
COPD, which is a direction for future studies . 
 DT and weather conditions aff ect physical activity 
levels in elderly people. 12 Th e diff erence in DT as a 
marker of the measured season infl uences the eff ects 
on physical activity seen in repeated measures and can 
be included as a confounder in intervention studies. 
Th is is in line with previous literature showing that 
seasonal variation has an important impact on the 
change in physical activity aft er rehabilitation 11 and 
concluding that season aff ects the change in STEPS. 37 
Th is fi nding may be less relevant to certain regions, 
such as equatorial Brazil where the mean temperature 
diff erence in winter compared with summer is less 
pronounced than in most European countries, sea-
sonal eff ects have been shown to be less present, 38 and 
diff erences in DT are less pronounced compared with 
Belgium (latitude 51°N). 
 Th e present study confi rms that patients with COPD 
perform most activities between 7:00  am and 8:00  pm . 14 
Compliance with wearing an activity monitor is a pre-
requisite for obtaining an accurate physical activity 
measurement. Research has concluded an excellent 
compliance with wearing the monitors day and night, 
supporting feasibility. 39 In overweight adults, reliable 
and comparable results were observed with 8, 10, and 
12 h of assessment. 40 This finding can be explained 
by the very low activity pattern of the studied popula-
tion, which is also common in the present COPD popu-
lation. 41 When physical activity is only measured during 
waking hours, we recommend defi ning days as non-
compliant when wearing time is  , 8 h. If data are avail-
able during night and day, we propose defining valid 
days as those with a minimum of 8 h of wearing time 
between 7:00  am and 8:00  pm . Exclusion of days 
 journal.publications.chestnet.org  325 
with  , 12 h of wearing time is not recommended 
because of the large drop in the number of subjects. 
 Aside from decreasing the variability of the measure-
ment, increasing the eff ect size (and subsequently the 
power) of the study can be achieved by increasing the 
magnitude of the intervention eff ect itself. Th e fact that 
enhanced physical activity is not guaranteed aft er pul-
monary rehabilitation programs can be due to a lack of 
eff ective behavior change. Th is behavior change prob-
ably needs more-specifi c interventions aimed at an 
increase in physical activity instead of exercise programs 
that primarily aim for an increase in functional capacity. 
More research on these programs is warranted, but pilot 
data using a combination of a step counter and online 
feedback seem promising. 42 Various strategies of pro-
cessing physical activity data have implications for the 
perceived impact of an intervention but do not change 
the magnitude of the eff ect itself. Th e latter is limited 
because no minimal clinically important diff erence has 
been established yet. 
 A few limitations should be considered when interpret-
ing the present data. First, the SenseWear armband pro-
vides accurate information on identifying minutes of 
moderate to intense activity but is less reliable as a step 
counter. 22 Th is multisensory activity monitor, worn at 
the arm and validated against both indirect calorimetry 
and doubly labeled water, is less accurate in identifying 
the number of steps. When expressed as the diff erence 
between steps measured by an activity monitor vs actual 
steps measured by manual counting, accelerometers 
worn at the arm less accurately represent the actual step 
count compared with leg activity monitors. 22,43 Th e number 
of steps measured in the present study may be underes-
timated, but although this may aff ect cross-sectional 
values, it is not likely to aff ect the interventional changes 
or the conclusions. Second, the activity measurement 
was restricted to 7 days. Whether more days of measure-
ment could have further decreased the sample size is not 
known. Increasing the assessment time is not feasible 
because patients may refuse to wear the monitors for 
longer periods. Th e majority of patients appear to be 
willing to wear activity monitors for up to 1 week. 23 In 
addition, measurement data at 5 days was almost iden-
tical to that at 4 days, so it is unlikely that longer periods 
would have changed the present conclusions. Th ird, it 
should be highlighted that through the proposed stan-
dardized way of measuring physical activity, we 
attempted to provide an optimal analysis of activity data 
from a statistical standpoint, but this does not neces-
sarily provide a more accurate representation or valida-
tion of the outcomes. Finally, although the main fi ndings 
apply to pulmonary rehabilitation, the proposed way of 
analyzing physical activity data likely will also be applicable 
to studies of other interventions because the measure-
ment methods mainly had an eff ect on the SD. Similarly, 
we suggest that our way of analysis can be generalized to 
other validated activity monitoring devices, in as far as 
their activity outcomes, (eg, step count), are validated. 
 Conclusions 
 Outcome measurements of number of steps and time in 
light activity (1.6-2.3 METs) assessed on at least 4 week-
days with a minimum of 8 h of monitor wearing time 
(during waking hours) with proper correction for a dif-
ference in DT reduce the noise in physical activity data 
and improve intervention responsiveness . Th ese fi nd-
ings have implications for trial design and data process-
ing and would potentially be cost saving for researchers 
on the one hand and helpful in measuring physical 
activity in the clinical routine for clinicians on the other 
hand by reducing the burden on patients. 
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